nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute treatment and prevention of stroke
|
Bath, Philip MW |
|
|
12 |
6S |
p. s69-s72 |
artikel |
2 |
Answers to self-assessment questions
|
|
|
|
12 |
6S |
p. s92 |
artikel |
3 |
Cardiovascular disease in patients with type 2 diabetes mellitus: vulnerable plaques and vulnerable blood
|
Viswanathan, GN |
|
|
12 |
6S |
p. s47-s50 |
artikel |
4 |
Evaluation and management of IgA nephropathy
|
Cheung, CK |
|
|
12 |
6S |
p. s27-s30 |
artikel |
5 |
Future treatments for Parkinson’s disease
|
Foltynie, Thomas |
|
|
12 |
6S |
p. s86-s90 |
artikel |
6 |
Global progress in tuberculosis vaccine development
|
Meyer, Joel |
|
|
12 |
6S |
p. s17-s20 |
artikel |
7 |
Horizons in Medicine 24: Molecules, mechanisms and medicines
|
Price, David A |
|
|
12 |
6S |
p. s1 |
artikel |
8 |
Infectious disease: bad luck or bad genes?
|
Chapman, Stephen J |
|
|
12 |
6S |
p. s12-s16 |
artikel |
9 |
Making sense of gut-brain signals
|
Dockray, Graham J |
|
|
12 |
6S |
p. s80-s84 |
artikel |
10 |
Phenotyping chronic obstructive pulmonary disease (COPD) exacerbations: realising personalised medicine
|
Brightling, Chris E |
|
|
12 |
6S |
p. s52-s56 |
artikel |
11 |
Recent advances in the risk assessment and treatment of osteoporosis
|
Compston, Juliet |
|
|
12 |
6S |
p. s2-s5 |
artikel |
12 |
Renal tubular acidosis: ‘RTA is no accident’
|
Wrong, Oliver M |
|
|
12 |
6S |
p. s22-s25 |
artikel |
13 |
Self-assessment questions: Acute treatment and prevention of stroke
|
Bath, Philip MW |
|
|
12 |
6S |
p. s73 |
artikel |
14 |
Self-assessment questions: Cardiovascular disease in patients with type 2 diabetes mellitus
|
Viswanathan, GN |
|
|
12 |
6S |
p. s51 |
artikel |
15 |
Self-assessment questions: Evaluation and management of IgA nephropathy
|
Cheung, CK |
|
|
12 |
6S |
p. s32 |
artikel |
16 |
Self-assessment questions: Future treatments for Parkinson’s disease
|
Foltynie, Thomas |
|
|
12 |
6S |
p. s91 |
artikel |
17 |
Self-assessment questions: Global progress in tuberculosis vaccine development
|
Meyer, Joel |
|
|
12 |
6S |
p. s21 |
artikel |
18 |
Self-assessment questions: Making sense of gut-brain signals
|
Dockray, Graham J |
|
|
12 |
6S |
p. s85 |
artikel |
19 |
Self-assessment questions: Phenotyping chronic obstructive pulmonary disease (COPD) exacerbations: realising personalised medicine
|
Brightling, Chris E |
|
|
12 |
6S |
p. s57 |
artikel |
20 |
Self-assessment questions: Recent advances in the risk assessment and treatment of osteoporosis
|
Compston, Juliet |
|
|
12 |
6S |
p. s6 |
artikel |
21 |
Self assessment questions: Renal tubular acidosis
|
Wrong, Oliver M |
|
|
12 |
6S |
p. s26 |
artikel |
22 |
Self-assessment questions: Targeting endogenous glucocorticoids in degenerative disease
|
Mackenzie, Scott D |
|
|
12 |
6S |
p. s63 |
artikel |
23 |
Self-assessment questions: The acute porphyrias
|
Rees, David C |
|
|
12 |
6S |
p. s41 |
artikel |
24 |
Self-assessment questions: The clinical impact of thyroid epidemiology
|
Leese, Graham P |
|
|
12 |
6S |
p. s68 |
artikel |
25 |
Self-assessment questions: The hepato-enteric immune axis in health and disease
|
Trivedi, Palak J |
|
|
12 |
6S |
p. s79 |
artikel |
26 |
Self-assessment questions: Tuberous sclerosis: from gene to targeted therapy
|
Davies, D Mark |
|
|
12 |
6S |
p. s11 |
artikel |
27 |
Targeting DNA base excision repair: a new strategy for personalised cancer therapy
|
Abbotts, Rachel |
|
|
12 |
6S |
p. s42-s46 |
artikel |
28 |
Targeting endogenous glucocorticoids in degenerative disease
|
Mackenzie, Scott D |
|
|
12 |
6S |
p. s58-s62 |
artikel |
29 |
The acute porphyrias
|
Rees, David C |
|
|
12 |
6S |
p. s37-s40 |
artikel |
30 |
The clinical impact of thyroid epidemiology
|
Leese, Graham P |
|
|
12 |
6S |
p. s64-s67 |
artikel |
31 |
The hepato-enteric immune axis in health and disease
|
Trivedi, Palak J |
|
|
12 |
6S |
p. s74-s78 |
artikel |
32 |
Therapeutic opportunities for lysosomal diseases affecting the brain
|
Cox, Timothy M |
|
|
12 |
6S |
p. s33-s36 |
artikel |
33 |
Tuberous sclerosis: from gene to targeted therapy
|
Davies, D Mark |
|
|
12 |
6S |
p. s7-s10 |
artikel |